WuXi Biologics (Cayman) Inc (WXXWY)
3.64
-0.14
(-3.70%)
USD |
OTCM |
Nov 22, 13:16
WuXi Biologics Total Liabilities (Quarterly): 1.577B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.577B |
| June 30, 2024 | 1.577B |
| December 31, 2023 | 1.772B |
| June 30, 2023 | 1.806B |
| June 30, 2023 | 1.806B |
| December 31, 2022 | 1.935B |
| June 30, 2022 | 1.789B |
| June 30, 2022 | 1.789B |
| December 31, 2021 | 1.777B |
| June 30, 2021 | 1.546B |
| June 30, 2021 | 1.546B |
| December 31, 2020 | 1.234B |
| Date | Value |
|---|---|
| June 30, 2020 | 979.44M |
| June 30, 2020 | 979.44M |
| December 31, 2019 | 672.62M |
| June 30, 2019 | 242.15M |
| June 30, 2019 | 242.15M |
| December 31, 2018 | 203.36M |
| June 30, 2018 | 159.80M |
| June 30, 2018 | 159.80M |
| December 31, 2017 | 126.30M |
| June 30, 2017 | 266.65M |
| June 30, 2017 | 266.65M |
| December 31, 2016 | 246.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
672.62M
Minimum
Dec 2019
1.935B
Maximum
Dec 2022
1.519B
Average
1.577B
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| Zai Lab Ltd | 317.68M |
| Sinovac Biotech Ltd | 1.390B |
| CASI Pharmaceuticals Inc | 49.77M |
| Adagene Inc | 44.19M |
| LakeShore Biopharma Co Ltd | 144.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.719B |
| Shareholders Equity (Quarterly) | 5.594B |
| Debt to Equity Ratio | 0.0531 |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 0.59% |